New advances promising in treating neuropathy. Expert explain what's the latest and best.
Neuropathies among HIV patients have continued to increase in recent years, particularly in the case of antiretroviral toxic neuropathy. Research data suggest that about one-third of HIV patients experience some form of neuropathy symptoms.
D016263:AIDS-Associated Nephropathy / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002211:Capsaicin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D000700:Analgesics; D009414:Nerve Growth Factors; D018894:Reverse Transcriptase Inhibitors; C101246:prosaptide; D002211:Capsaicin